Drug recall · December 23, 2020
Kaiser Permanente Clotrimazole Cream USP recall
Why: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Kaiser Permanente Clotrimazole Cream USP, 1% Antifungal Cream, NET WT 1 oz (28.4 g), Manufactured by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T1C1 Distributed by Kaiser Foundation Hospitals Livemore, CA 94551-9756. Made in Canada. NDC 0179-8014-30
- Lots / codes
Lot#: A873630634, Exp Dec 2020; B870030634, Exp, Jan 2021
- Quantity
- 30,816 1 oz tubes
- Company
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
- Distribution
- Distributed Nationwide in the USA and Canada
- Initiated
- November 17, 2020 · Voluntary: Firm initiated
- Classified
- December 16, 2020
- Reported
- December 23, 2020
- Ended
- February 21, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clotrimazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.